Phase 1/2a Trial of YH12852 in Healthy Subjects and Patients With Functional Constipation
Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
A randomized, double-blind/open-label, placebo/active-controlled, single/multiple dose,
parallel, phase 1/2a trial to evaluate the safety, tolerability, pharmacokinetics and
pharmacodynamics of YH12852 in healthy subjects and patients with functional constipation